All articles tagged with #vision loss
A large look at FDA adverse-event data suggests Wegovy (high-dose semaglutide) has a rare link to NAION, an “eye stroke” that can cause sudden vision loss, with men at higher risk than women. Wegovy shows a stronger association than Ozempic, possibly due to rapid weight loss and blood‑pressure fluctuations, but the overall risk remains very small and more research is needed.
Tattoo-associated uveitis is a rare immune-driven eye inflammation that can occur after getting a tattoo, potentially allowing ink-related immune responses to breach the eye’s blood-ocular barrier. While most people don’t react to tattoo inks, some develop inflammation in the uvea that can lead to glaucoma, cataracts, or permanent vision loss if untreated. Larger tattoos and black ink may pose higher risk, and individuals with autoimmune or inflammatory conditions might be more susceptible. Treatments include steroid eye drops or injections and, in some cases, long-term immunosuppressants, but about 75% experience temporary vision loss and 17% permanent loss. If you notice swelling, pain, or redness around the eye, seek prompt evaluation from an optometrist or ophthalmologist; the number of cases may rise as tattoos remain popular.
Tattoo-associated uveitis is a rare condition where chemicals in tattoo ink trigger an immune reaction that can breach the eye’s blood-ocular barrier and inflame the uvea, potentially causing pain, redness and light sensitivity. If left untreated, it may lead to glaucoma or cataracts and permanent vision loss. Australian studies show rising cases, with larger tattoos and black ink more often implicated, and risk factors including immune-related conditions like multiple sclerosis or certain arthritides. Treatments include steroid eye drops or injections and immunosuppressants, but outcomes vary (roughly 75% temporary vision loss and 17% permanent in some cases). If eye swelling or vision problems occur after a tattoo, consult an optometrist promptly for evaluation and possible referral to a specialist.
David Furnish says Elton John is keeping busy and moving forward despite ongoing health issues, enjoying family time at home with their sons as they prepare for the Elton John AIDS Foundation Oscars Viewing Party; John has previously discussed vision loss and mobility challenges from past injuries.
Researchers report 40 new Australian cases of tattoo-associated uveitis, a rare inflammatory eye condition that can cause glaucoma and permanent vision loss; cases often appear years after tattooing and largely involve black ink. Most patients require long-term immunosuppressants, leading experts to call for more research into ink ingredients and safer alternatives.
Acanthamoeba keratitis is a rare but serious eye infection primarily affecting contact lens wearers, caused by a parasite found in water and soil, which can lead to permanent vision loss if not diagnosed and treated early. Proper lens hygiene, avoiding water contact, and prompt medical attention are crucial for prevention and management.
Recent research identifies high LDL cholesterol in mid-life and untreated vision loss as two new, modifiable risk factors for dementia, accounting for about 9% of cases globally. Early detection and management of these factors through lifestyle changes, medical intervention, and regular health check-ups can significantly reduce the risk of developing dementia.
Judi Dench has revealed that her eye condition has worsened to the point where she cannot recognize people or see clearly, leading her to step back from acting. Despite her visual challenges, she maintains a good sense of humor and is exploring ways to adapt, such as using technology to help with learning lines.
Researchers have identified two new modifiable risk factors for dementia: high cholesterol after age 40 and untreated vision loss, adding to previously known factors like physical inactivity and smoking. Managing these risks through medical care and lifestyle changes can potentially prevent nearly half of dementia cases worldwide.
Researchers have identified two new modifiable risk factors for dementia: high cholesterol after 40 and untreated vision loss, adding to previously known factors like physical inactivity and smoking. Managing these risks through medical care and lifestyle changes can potentially prevent nearly half of dementia cases worldwide.
A 26-year-old woman, McEwen Baker, shares her emotional journey of gradually losing her vision due to corneal damage and inflammation, undergoing multiple surgeries, and coping with her diagnosis through social media and support groups, highlighting the challenges and resilience involved in her condition.
A 26-year-old woman, McEwen Baker, is documenting her rapid progression to blindness due to corneal cell death and her emotional journey through this life-changing experience, seeking community and support online.
Teresa Puthussery, a UC Berkeley vision scientist, received the 2025 MacArthur 'genius' award for her groundbreaking research on retinal cells, which could lead to new treatments for eye diseases and vision restoration. Her work focuses on understanding how different retinal cells encode visual information and developing innovative therapies for degenerative eye conditions.
Ozempic, a popular drug for weight loss and diabetes, is facing numerous lawsuits due to alleged severe side effects, especially irreversible vision loss from NAION, with regulatory bodies and studies supporting a potential link. The legal battle is intensifying, with significant financial and reputational risks for Novo Nordisk, as plaintiffs share personal stories and courts consider the evidence. The outcome could reshape pharmaceutical accountability and drug safety standards.
Recent studies on semaglutide, a GLP-1 medication, show conflicting results regarding its link to eye problems. While some research suggests a possible association with nonarteritic anterior ischemic optic neuropathy (NAION), overall evidence is inconclusive, and the medication appears not to significantly increase the risk of diabetic retinopathy or other eye disorders. Experts recommend ongoing research and regular eye exams for users.